Solara Active Pharma Sciences informs about change in KMP

14 Mar 2022 Evaluate

With reference to its earlier communication dated March 9, 2022, wherein the company had mentioned that S. Hariharan's designation as Chief Financial Officer instead of Executive Director and Chief Financial Officer. S. Hariharan is not debarred from holding office of director by virtue of any order by the Securities and Exchange Board of India or any other such authority. The company has attached updated annexure.

The above information is a part of company’s filings submitted to BSE.


Solara Active Pharma Share Price

771.35 -3.20 (-0.41%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.